
|Articles|February 4, 2022
Pharmacy Clinical Pearl of the Day: Graves’ Disease
Author(s)Saro Arakelians, PharmD
Graves' disease is more common among women and in people younger than 40 years of age.
Advertisement
Clinical Pearl of the Day: Graves’ Disease
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism).
Insight:
- Although several disorders may result in hyperthyroidism, Graves' disease is a common cause.
- Although Graves' disease may affect anyone, it's more common among women and in people younger than 40 years of age.
- The primary treatment goals are to reduce the number of thyroid hormones that the body produces and lessen the severity of symptoms.
- Symptoms may include anxiety, fine tremor of the hands and fingers, heat sensitivity, weight loss, enlargement of the thyroid, erectile dysfunction, and bulging eyes.
- Causes: Graves' disease is caused by a malfunction in the body's disease-fighting immune system. It's unknown why this happens.
- Risk factors: Age, family history, physical stress, pregnancy, and smoking.
- Diagnosis: Blood test, radioactive iodine uptake, ultrasound, and imaging tests.
- Treatment: Radioactive iodine therapy, anti-thyroid medications including methimazole (Tapazole), propylthiouracil, and beta blockers.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























